Document:

EX-4.1

 Exhibit 4.1 
  

			
		  	EXECUTION VERSION

 SUBSCRIPTION AND PURCHASE AGREEMENT 

This SUBSCRIPTION AND PURCHASE AGREEMENT, dated as of March 28, 2019 (this “ Agreement”), is entered into by and between
LegalApp Holdings, Inc., a Delaware corporation (the “Company”) and HLUS Holdings LLC, a Delaware limited liability company (the “Purchaser”). 

WHEREAS, the Company intends to issue and sell to the Purchaser, and the Purchaser intends to purchase from the Company, shares of common
stock of the Company, par value $0.001 per share (the “Common Stock”); and 
 WHEREAS, concurrently with the execution of
this Agreement, the Purchaser is delivering a joinder agreement to the Amended and Restated Stockholders Agreement, dated as of April 27, 2017 (as amended hereafter from time to time, the “Stockholders Agreement”), by and among
the Company and its stockholders. 
 NOW, THEREFORE, in consideration of the foregoing and the representations, covenants and agreements
contained herein and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto, intending to be legally bound, agree as follows: 

SECTION 1.    Certain Defined Terms. For purposes of this Agreements, the following terms shall have the meanings
set forth below: 
 “Affiliate” means, with respect to any specified Person, any other Person that directly, or indirectly
through one or more intermediaries, controls, is controlled by, or is under common control with, such specified Person. The word “control” (including the terms “controlled by” and “under common control with”), with
respect to the relationship between or among two or more Persons, means the possession, directly or indirectly or as trustee, personal representative or executor, of the power to direct or cause the direction of the affairs or management of a
Person, whether through the ownership of voting securities, as trustee, personal representative or executor, by contract, credit arrangement or otherwise. 

“Agreement” has the meaning set forth in the preamble. 

“Common Stock” has the meaning set forth in the recitals. 

“Company” has the meaning set forth in the preamble. 

“Evaluation Material” has the meaning set forth in Section 4(l). 

“Indemnified Party” has the meaning set forth in Section 8(d). 

“Indemnifying Party” has the meaning set forth in Section 8(d). 

“Liability” has the meaning set forth in Section 7(b). 

“Loss” has the meaning set forth in Section 8(b). 

  
 1 

 “Person” means any individual, corporation, partnership, firm, joint
venture, association, joint enterprise, joint-stock company, trust, unincorporated organization, governmental authority or other entity. 

“Other Indemnified Persons” has the meaning set forth in Section 7(c). 

“Purchase Price” has the meaning set forth in Section 2(a). 

“Purchaser” has the meaning set forth in the preamble. 

“Purchaser Indemnified Persons” has the meaning set forth in Section 7(b). 

“Shares” has the meaning set forth in Section 2(a). 

“Securities Act” means the Securities Act of 1933, as amended. 

“Selling Stockholders” has the meaning set forth in Section 7(a). 

“Stockholders Agreement” has the meaning set forth in the recitals. 

“Transfer” means any direct or indirect transfer, donation, sale, assignment, pledge, hypothecation, grant of a security
interest in or other disposal or attempted disposal of all or any portion of a security, any interest or rights in a security, or any rights under this Agreement. “Transferred” means the accomplishment of a Transfer, and
“Transferee” means the recipient of a Transfer. 
 SECTION 2.    Issuance and Sale of Common Stock.

 (a)    The Company hereby issues and sells to the Purchaser, and the Purchaser hereby purchases from the Company,
250,000 shares of Common Stock (the “Shares”), for a purchase price of $12 per share and $3,000,000 in the aggregate (the “Purchase Price”). 

(b)    Simultaneously with the execution of this Agreement, the Purchaser is delivering to the Company the Purchase Price
by wire transfer in immediately available funds to the bank account designated by the Company. 
 (c)    Promptly after
the execution of this Agreement, the Company shall deliver a stock certificate evidencing the issuance of the Shares to the Purchaser. 

SECTION 3.    Representations and Warranties of the Company. The Company hereby represents and warrants to the
Purchaser as follows: 
 (a)    Organization, Power and Standing. The Company is a corporation, duly organized,
validly existing and in good standing under the laws of the State of Delaware, and has all necessary corporate power and authority (i) to enter into this Agreement, to carry out its obligations hereunder and to consummate the transactions
contemplated hereby and (ii) to own lease and operate its properties and carry on its business as presently owned, leased, operated or conducted. 

  
 2 

 (b)    Authorization, Validity and Enforceability. The execution
and delivery of this Agreement by the Company, the performance by the Company of its obligations hereunder and the consummation by the Company of the transactions contemplated hereby have been duly authorized by all requisite corporate or other
action on the part of the Company. This Agreement has been duly executed and delivered by the Company, and (assuming due authorization, execution and delivery by the Purchaser) this Agreement constitutes legal, valid and binding obligations of the
Company, enforceable against the Company in accordance with its terms, except as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application affecting enforcement of
creditors’ rights generally. 
 (c)    No Conflicts. The execution, delivery and performance of this
Agreement by the Company does not (i) conflict with or result in a breach of the organizational documents of the Company, (ii) conflict with or violate any law or governmental order applicable to the Company, (iii) conflict with,
result in any breach of, constitute a default (or event which with the giving of notice or lapse of time, or both, would become a default) under, any note, bond, mortgage or indenture, contract, lease, sublease, license, permit, franchise or other
instrument or arrangement to which the Company is a party or by which any of such properties is bound or affected, except, in each case, as would not be material to the Company. 

(d)    Capitalization. As of immediately prior to the issuance of the Shares, there were (i) fifty-five
million (55,000,000) authorized shares of Common Stock, of which twenty-three million three hundred twenty-three thousand six hundred seventy (23,323,670) shares were issued and outstanding and (ii) eighteen million twenty-three thousand eight
hundred eighty-six (18,023,886) authorized shares of preferred stock, of which seventeen million seven hundred sixty-two thousand three hundred seventy-nine (17,762,379)
shares were issued and outstanding. 
 (e)    Issuance of the Shares. The Shares, when issued and paid for in
accordance with this Agreement, will be duly and validly issued and outstanding, fully paid and non-assessable. The Purchaser will acquire good and marketable title to the Shares, free and clear of any liens,
encumbrances, security interests, claims, or restrictions, other than restrictions under the Stockholders Agreement, this Agreement or applicable securities laws. 

(f)    No Broker. No broker, finder, investment banker or other Person is entitled to any brokerage, finder’s
or other fee or commission in connection with the transactions contemplated by this Agreement based upon arrangements made by the Company. 

SECTION 4.    Representations and Warranties of the Purchaser. The Purchaser hereby represents and warrants to the
Company as follows: 
 (a)    Organization, Power and Standing. The Purchaser is a limited liability company,
duly organized, validly existing and in good standing under the laws of the State of Delaware, and has all necessary company power and authority (i) to enter into this Agreement, to carry out its obligations hereunder and to consummate the
transactions contemplated hereby and (ii) to own lease and operate its properties and carry on its business as presently owned, leased, operated or conducted. 

  
 3 

 (b)    Authorization, Validity and Enforceability. The execution
and delivery of this Agreement by the Purchaser, the performance by the Purchaser of its obligations hereunder and the consummation by the Purchaser of the transactions contemplated hereby have been duly authorized by all requisite corporate or
other action on the part of the Purchaser. This Agreement has been duly executed and delivered by the Purchaser, and (assuming due authorization, execution and delivery by the Company) this Agreement constitutes legal, valid and binding obligations
of the Purchaser, enforceable against the Purchaser in accordance with its terms, except as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application affecting
enforcement of creditors’ rights generally. 
 (c)    No Conflicts. The execution, delivery and performance
of this Agreement by the Purchaser does not (i) conflict with or result in a breach of the organizational documents of the Purchaser, (ii) conflict with or violate any law or governmental order applicable to the Purchaser,
(iii) conflict with, result in any breach of, constitute a default (or event which with the giving of notice or lapse of time, or both, would become a default) under, any note, bond, mortgage or indenture, contract, lease, sublease, license,
permit, franchise or other instrument or arrangement to which the Purchaser is a party or by which any of such properties is bound or affected. 

(d)    Purchase Entirely for Own Account. The Shares are being acquired by the Purchaser solely for the
Purchaser’s own account, for investment purposes only and with no present intention of distributing, selling or otherwise disposing of them in connection with a distribution. By executing this Agreement, the Purchaser further represents that
the Purchaser does not presently have any contract, undertaking, agreement or understanding with any person to sell or transfer any of the Shares. 

(e)    Restricted Securities. The Purchaser understands that the Shares have not been registered under the
Securities Act by reason of a specific exemption from the registration provisions of the Securities Act, the availability of which depends upon, among other things, the bona fide nature of the investment intent and the accuracy of the
Purchaser’s representations as expressed herein or otherwise made pursuant hereto. The Purchaser understands that the Shares are “restricted securities” and may not be sold, transferred or otherwise disposed of by the Purchaser
without registration under the Securities Act and any applicable state securities laws, or an exemption therefrom, and that in the absence of an effective registration statement covering such Shares or an available exemption from registration, the
Shares may be required to be held indefinitely. The Purchaser is aware that the Shares may not be sold pursuant to Rule 144 promulgated under the Securities Act unless all of the conditions of that Rule are met. The Purchaser understands that this
offering is not intended to be part of a public offering, and that the Purchaser will not be able to rely on the protection of Section 11 of the Securities Act. 

(f)    No Public Market. The Purchaser understands and acknowledges that no public market now exists for any of the
Shares issued by the Company and that the Company has made no assurances that a public market will ever exist for the Company’s shares. 

  
 4 

 (g)    Accredited Investor. The Purchaser is (i) a
“qualified institutional buyer” as defined in Rule 144A promulgated under the Securities Act or (ii) an “accredited investor” as defined in Rule 501(a)(1), (2), (3), or (7) of Regulation D promulgated under the
Securities Act. Neither the Purchaser nor any of its equity owners is subject to any “Bad Actor” disqualifications described on Rule 506(d)(1)(i) to (viii) of Regulation D promulgated under the Securities Act. 

(h)    Transfer Restrictions. The Purchaser understands that (i) the Shares may only be transferred in
accordance with this Agreement, the Stockholders Agreement and applicable securities laws and that substantial restrictions (pursuant to this Agreement, the Stockholders Agreement and applicable securities laws) will exist on the transferability of
the Shares and (ii) the Purchaser may not be able to liquidate its investment in the Company. 
 (i)    Future
Financings. The Purchaser understands and acknowledges that the Company may complete additional financings in the future in order to develop the proposed business of the Company and to fund its ongoing development. There is no assurance that any
such financings will be available and, if available, on reasonable terms and the Purchaser does not have any contractual right to participate in such financings. Any such financings may have a dilutive effect on current shareholders, including the
Purchaser. If such future financings are not available, the Company may be unable to fund its ongoing development and the lack of capital resources may result in the failure of its business venture. 

(j)    Sophisticated Investor. The Purchaser has substantial experience in evaluating and investing in private
placement transactions of securities in companies similar to the Company. The Purchaser is able to bear the economic risk of an investment in the Shares and has such knowledge and experience in financial and business matters that the Purchaser is
capable of evaluating the merits and risks of the proposed investment. The Purchaser has had an opportunity to discuss the Company’s business, management, financial affairs and the terms and conditions of the offering of the Shares with the
Company’s management. 
 (k)    Independent Investigation. The Purchaser has conducted its own independent
investigation, review and analysis of, and reached its own independent conclusions regarding, the Company and its operations, assets, condition (financial or otherwise) and prospects. The Purchaser and its representatives have been provided such
access to the personnel, properties, premises, records and other documents and information of and relating to the Company as it has requested for such purpose. The Purchaser has been represented by, and had the assistance of, counsel in the conduct
of its due diligence, the preparation and negotiation of this Agreement, and the consummation of the transactions contemplated hereby and thereby. 

(l)    No Other Representations. The Purchaser acknowledges and agrees that other than the representations and
warranties expressly made by the Company in this Agreement, none of the Company, any of the Company’s representatives or any other Person has made or makes any representation or warranty, written or oral, express or implied, at law or in
equity, with respect to the Company, including any representation or warranty as to merchantability or fitness for a particular use or purpose. None of the Company or any of its representatives have made, and shall not be deemed to have made, any
representations or warranties in the information or materials relating to the Company or its business made available to the Purchaser and its representatives, including projections, due diligence materials, data room materials, or in any
presentation by management of the Company or others in connection with the transactions contemplated hereby (collectively, the “Evaluation Material”), and no statement contained in any 

  
 5 

 
of such information or materials or made in any such presentation shall be deemed a representation or warranty hereunder or otherwise or deemed to be relied upon by the Purchaser in executing,
delivering and performing this Agreement and the transactions contemplated hereby and the Purchaser represents that it has not relied on any Evaluation Material. In entering into this Agreement, the Purchaser acknowledges that it has not relied on
and is not relying on any representation, warranty or other statement made by, on behalf of or relating to the Company, except for the representations and warranties expressly set forth in this Agreement. 

(m)    No Broker. No broker, finder, investment banker or other Person is entitled to any brokerage, finder’s
or other fee or commission in connection with the transactions contemplated by this Agreement based upon arrangements made by, or on behalf of, the Purchaser. 

SECTION 5.    Transfer Restrictions. In addition to the Transfer restrictions set forth in the Stockholders
Agreement, the Purchaser shall not Transfer all or any portion of the Shares or any shares of capital stock of the Company hereafter acquired, except (a) for a Transfer to any Affiliate of the Purchaser (including future investment funds that
have affiliated but not identical general partners), (b) pursuant to Transfers required to be consummated by the Purchaser under the Stockholders Agreement, (c) for Transfers to the Company or (d) with the prior written approval of each
Major Investor (as defined in the Stockholders Agreement); provided that, in case of clauses (a) and (d), the Purchaser shall cause the transferee of such shares to assume the obligations under this Agreement and the Stockholders
Agreement prior to the consummation of such Transfer. The restrictions set forth in this Section 5 shall terminate upon a Sale Event (as defined in the Stockholders Agreement) or a QPO (as defined in the Company’s
Fifth Amended and Restated Certificate of Incorporation). 
 SECTION 6.    Financial Information. Notwithstanding
the fact that the Purchaser will not be a 5% Holder (as defined in the Stockholders Agreement), the Company shall furnish to the Purchaser the financial information contemplated to be furnished to 5% Holders pursuant to Section 7.1(a) and
Section 7.1(b) of the Stockholders Agreement in accordance with the terms thereof. In addition, the Purchaser may from time to time (but not more than once per calendar quarter) submit a written inquiry to the Company as to whether the Company
has in a new primary issuance issued shares of capital stock (excluding issuances due to option or warrant exercises), in which case the Company shall inform the Purchaser as to whether any such new issuances of shares of capital stock have occurred
and, if such issuance has occurred, the valuation of the Company implied by such issuance. 
 SECTION 7.    Piggyback
Registration Rights. 
 (a)    Registration Rights. If the Company at any time proposes to register any of
its shares of Common Stock under the Securities Act for sale to the public (except with respect to registration statements on Forms S-4, S-8 or another form not
available for registering such shares for sale to the public), then, for as long as the Purchaser owns any shares of Common Stock of the Company, each such time it will give written notice at the applicable address of record to the Purchaser of its
intention to do so. Upon the written request of the Purchaser, given within twenty (20) days after receipt by the Purchaser of such notice, the Company will, subject to the limits contained in this Section 7, use its
best efforts to cause all such shares of Common 

  
 6 

 
Stock of the Purchaser to be registered under the Securities Act and qualified for sale under any state blue sky law, all to the extent required to permit such sale or other disposition of such
shares of Common Stock; provided, however, that if the Company is advised in writing in good faith by any managing underwriter of the Company’s securities being offered in a public offering pursuant to such registration statement
that the amount to be sold by persons other than the Company (collectively, the “Selling Stockholders”) is greater than the amount which can be offered without adversely affecting the offering, the Company may reduce the amount
offered for the accounts of the Selling Stockholders (including the Purchaser) to a number deemed satisfactory by such managing underwriter. 

(b)    Indemnification by the Company. The Company shall indemnify and hold harmless the Purchaser (including its
partners (including partners of partners and shareholders of such partners)) and directors, officers, employees and agents of the Purchaser, and each other Person who participates in the offering of such securities and each other Person, if any, who
controls (within the meaning of the Securities Act) the Purchaser (collectively, the “Purchaser Indemnified Persons”) against any losses, claims, damages or liabilities (collectively, “Liability”), joint or several,
to which such Purchaser Indemnified Person may become subject under the Securities Act or any other statute or at common law, insofar as such Liability (or action in respect thereof) arises out of or is based upon (i) any untrue statement or
alleged untrue statement of any material fact contained, on the effective date thereof, in any registration statement under which such securities were registered under the Securities Act, any preliminary prospectus or final prospectus contained
therein, or any amendment or supplement thereto, or any free writing prospectus used in connection with any offering, including but not limited to, any free writing prospectus used by the Company, the underwriters or the stockholders of the Company,
or (ii) any omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading, or (iii) any violation by the Company of the Securities Act, any state
securities or “blue sky” laws or any sale or regulation thereunder in connection with such registration. The Company shall reimburse each such Purchaser Indemnified Person in connection with investigating or defending any such Liability;
provided, however, that the Company shall not be liable to any Indemnified Person in any such case to the extent that any such Liability arises out of or is based upon any untrue statement or alleged untrue statement or omission or
alleged omission made in such registration statement, preliminary or final prospectus, or amendment or supplement thereto, free writing prospectus, or other information, in reliance upon and in conformity with information furnished in writing to the
Company by the Purchaser specifically for use therein; provided, further, that the Company shall not be required to indemnify any Person against any liability arising from any untrue or misleading statement or omission contained in any
preliminary prospectus if such deficiency is corrected in the final prospectus or for any Liability which arises out of the failure of any Person to deliver a prospectus as required by the Securities Act regardless of any investigation made by or on
behalf of such Purchaser Indemnified Person and shall survive transfer of such securities by the Purchaser. 

(c)    Indemnification by the Purchaser. If any of the Purchaser’s securities are included in a registration
being effected, the Purchaser shall indemnify and hold harmless each other selling holder of any securities, the Company, its directors and officers, employees and agents, each underwriter and each other Person, if any, who controls (within the
meaning of the Securities Act) the Company or such underwriter (collectively, the “Other Indemnified 

  
 7 

 
Persons”), against any Liability, joint or several, to which any such Other Indemnified Person may become subject under the Securities Act or any other statute or at common law,
insofar as such Liability (or actions in respect thereof) arises out of or is based upon (i) any untrue statement or alleged untrue statement of any material fact contained, on the effective date thereof, in any registration statement under
which securities were registered under the Securities Act at the request of the Purchaser, any preliminary prospectus or final prospectus contained therein, or any amendment or supplement thereto, or any free writing prospectus used in connection
with such offering, including but not limited to, any free writing prospectus used by the Company, the underwriters or the any stockholder of the Company, or (ii) any omission or alleged omission by the Purchaser to state therein a material
fact required to be stated therein or necessary to make the statements therein not misleading, or (iii) any information provided at the instruction of the Purchaser to any Person participating in the offer at the point of sale containing any
untrue statement or alleged untrue statement of any material fact or omitting or allegedly omitting any material fact required to be included in such information or necessary to make the statements therein not misleading, in the case of (i), (ii)
and (iii) to the extent, but only to the extent, that such untrue statement or alleged untrue statement or omission or alleged omission was made in such registration statement, preliminary or final prospectus, amendment or supplement thereto,
free writing prospectus, or other information, in reliance upon and in conformity with information furnished in writing to the Company by the Purchaser specifically for use therein. The Purchaser shall reimburse any Other Indemnified Person for any
legal fees incurred in investigating or defending any such Liability; provided, however, that in no event shall the Liability of the Purchaser for indemnification under this Section 7(c) in its capacity as a
seller of Registrable Securities exceed the lesser of (i) that proportion of the total of such losses, claims, damages, expenses or liabilities indemnified against equal to the proportion of the total securities sold under such registration
statement which is being held by the Purchaser, or (ii) the amount equal to the proceeds to the Purchaser of the securities sold in any such registration; provided, further, that no selling Stockholder shall be required to
indemnify any Person against any Liability arising from any untrue or misleading statement or omission contained in any preliminary prospectus if such deficiency is corrected in the final prospectus or for any Liability which arises out of the
failure of any Person to deliver a prospectus as required by the Securities Act. 
 (d)    Termination. The right
of the Purchaser to request inclusion of securities in any registration pursuant to Section 7(a) shall terminate upon the earliest to occur of: (i) a Deemed Liquidation Event (as defined in the in the Company’s
Fifth Amended and Restated Certificate of Incorporation), (ii) such time after consummation of the QPO (as defined in the Company’s Fifth Amended and Restated Certificate of Incorporation) as Rule 144 or another similar exemption under the
Securities Act is available for the sale of all of the Purchaser’s shares without limitation during a three-month period without registration, or (iii) the second anniversary of the QPO (as defined in the Company’s Fifth Amended and
Restated Certificate of Incorporation). 
 SECTION 8.    Indemnification. 

(a)    Survival. The representations and warranties contained herein and all related rights to indemnification
shall survive the Closing for a period of eighteen (18) months. The covenants set forth herein shall survive until the expiration of the term or period specified therein. 

  
 8 

 (b)    Indemnification by the Company. In connection with the
Purchaser’s subscription and purchase of the Shares, the Company shall indemnify and hold harmless the Purchaser and its Affiliates, and its and their officers, directors and employees against Liabilities actually incurred by them arising out
of or resulting from the breach of (i) any representation or warranty made by the Company in this Agreement and (ii) any covenant entered into by the Company in this Agreement. In no event shall the aggregate liability of the Company under
or in connection with Section 8(b)(i) exceed the Purchase Price. 
 (c)    Indemnification
by the Purchaser. In connection with the Company’s issuance and sale of the Shares, the Purchaser, shall indemnify and hold harmless the Company and all of their respective Affiliates and its and their officers, directors and employees
against all Liabilities actually incurred arising out of or resulting from the breach of (i) any representation or warranty made by the Purchaser in this Agreement and (ii) any covenant entered into by the Purchaser in this Agreement. 

(d)    Indemnification Procedures. Whenever any claim shall arise for indemnification hereunder, the party entitled
to indemnification (the “Indemnified Party”) shall promptly provide written notice of such claim to the other party (the “Indemnifying Party”). Such notice shall describe the claim in reasonable detail and, to the
extent practicable, an estimate of the Liability therefor. In connection with any action or proceeding by a Person who is not a party to this Agreement with respect to which a party to this Agreement may be obligated to provide indemnification
pursuant to this Section 8, the Indemnifying Party, at its sole cost and expense and upon written notice to the Indemnified Party, may assume the defense of any such action within 30 days of the Indemnifying Party receiving
notice of such claim, and the Indemnified Party shall reasonably cooperate with the defense of such claim. The Indemnified Party shall be entitled to participate in the defense of any such action, with its counsel and at its own cost and expense. If
the Indemnifying Party does not assume the defense of any such action, the Indemnified Party shall defend against such action in such manner as it may reasonably deem appropriate; provided that the Indemnified Party shall not settle such
action without the consent of the Indemnifying Party (which consent shall not be unreasonably withheld, conditioned or delayed). 

(e)    Exclusive Remedy. (i) This Section 8, Sections 7(b) and 7(c)
shall be the sole and exclusive monetary remedy of the Indemnified Parties (including the Purchaser and the Company) in connection with this Agreement and the transactions contemplated hereby, (ii) except as set forth in
Section 9(l), neither the Purchaser nor the Company shall be liable or responsible in any manner whatsoever (whether for indemnification or otherwise) to any Indemnified Party for a breach of this Agreement or in
connection with any of the transactions contemplated by this Agreement, including the issuance of the Shares pursuant hereto, except pursuant to the indemnification provisions set forth in this Section 8 and
Sections 7(b) and 7(c), and (iii) each party hereto hereby waives, to the fullest extent permitted under applicable Law, any and all rights, claims and causes of action (A) for any breach of any representation, warranty,
covenant, agreement or obligation set forth herein or (B) otherwise relating to the subject matter of this Agreement, in each case, that it may have against the other Party and its Representatives arising under or based upon any applicable Law,
except pursuant to the indemnification provisions set forth in this this Section 8 and Sections 7(b) and 7(c) and Section 9(l). 

  
 9 

 SECTION 9.    Miscellaneous Provisions. 

(a)    Confidentiality. 

(i)    The Purchaser shall not, and shall cause its Affiliates not to, make any press release or public
announcement disclosing the existence of this Agreement or make known publicly any facts related to the transactions contemplated herein, except (A) that the Purchaser may only disclose that this Agreement was entered into (but shall not disclose
the price of the Shares, the amount of the investment, the valuation of the Company, its percentage ownership in the Company or the specific terms of this Agreement), and the Purchaser may answer questions from research analysts regarding the fact
that the Purchaser holds an interest in the Company (provided that such disclosure is limited to the fact that this Agreement was entered into (but shall not disclose the price of the Shares, the amount of the investment, the valuation of the
Company, its percentage ownership in the Company or the specific terms of this Agreement)), (B) if no other information is provided by the Purchaser at any other time (including the price of the Shares, the identity of the Company, the valuation of
the Company, its percentage ownership in the Company or the terms of this Agreement), the Purchaser may disclose the fact that it made an investment in the amount of $3 million in a technology related business, (C) with the prior written
consent of the Company or (D) as required by applicable law, regulation or United States Generally Accepted Accounting Principles (provided, however, that any disclosure in accordance with this clause (D) shall be limited to the
minimum amount of information required to comply with such obligation). For the avoidance of doubt, it is the Parties’ understanding that the Purchaser will not be required pursuant to applicable law, regulation or United States Generally
Accepted Accounting Principles to disclose the per share price for the Shares, the valuation of the Company implied thereby or any future valuation of the Company. Notwithstanding the foregoing, (i) the Purchaser may not make or cause to be
issued a press release with respect to the Company or its investment without the prior written consent of the Company and (ii) no disclosure shall be made in the event that legal counsel to the Company advises that such disclosure may conflict
with, or violate applicable Law in connection with, an initial public offering of the Company. 

(ii)    Subject to Section 9(a)(i), the Purchaser shall comply with the terms of
Section 7.8 of the Stockholders Agreement with respect to all confidential information made available by the Company to the Purchaser, including information made available under Section 6. 

(b)    Limitation on Damages. In no event shall any party hereto have any liability under or in connection with
this Agreement for punitive, exemplary, special, indirect or consequential damages, damages for lost profits, damages for diminution in value or damages computed on a multiple of earnings basis. 

  
 10 

 (c)    Expenses. All costs and expenses, including fees and
disbursements of counsel, financial advisors and accountants, incurred in connection with this Agreement and the transactions contemplated by this Agreement shall be paid by the party incurring such costs and expenses. 

(d)    Notices. All notices and other communications under this Agreement shall be in writing and shall be deemed
given when delivered personally by hand or by overnight courier or other delivery method or when sent by electronic mail transmission (provided that, in the case of electronic mail transmission, either receipt of such electronic mail is
acknowledged by the applicable recipient or a confirmatory hardcopy is sent without undue delay by an internationally recognized courier service), in each case, to the following physical and electronic mail addresses (or to such other physical and
electronic mail address as a party hereto may have specified by notice pursuant to this provision): 
 (i)    if to the
Company, to the address set forth below: 
 LegalApp Holdings, Inc. 

200 Portage Avenue 
 Palo Alto,
California 94306 
 Attn:        Chief Financial Officer 

E-Mail:    stephen.robertson@intapp.com 

with a copy (which shall not constitute service) to: 

(Before June 15, 2019) 

DealCloud, Inc. 
 129 West Trade
Street 
 Suite 1025 

Charlotte, North Carolina 28202 

Attn:        General Counsel 

E-Mail:    legal@intapp.com 

(On and after June 15, 2019) 

DealCloud, Inc. 
 300 South
Tryon Street 
 Suite 1200 

Charlotte, North Carolina 28202 

Attn:        General Counsel 

E-Mail:    legal@intapp.com 

  
 11 

 (ii)    if to the Purchaser, to the address set forth below: 

HLUS Holdings LLC 
 1
Presidential Blvd, 4th Floor 
 Bala Cynwyd, Pennsylvania 19004 

Attn:     Kristin Jumper 

E-Mail: kjumper@hamiltonlane.com 

(e)    Severability. If any term or other provision of this Agreement is invalid, illegal or incapable of being
enforced by any law or public policy, all other terms and provisions of this Agreement shall nevertheless remain in full force and effect for so long as the economic or legal substance of the transactions contemplated hereby is not affected in any
manner materially adverse to either party hereto. Upon such determination that any term or other provision is invalid, illegal or incapable of being enforced, the parties hereto shall negotiate in good faith to modify this Agreement so as to effect
the original intent of the parties as closely as possible in an acceptable manner in order that the transactions contemplated hereby are consummated as originally contemplated to the greatest extent possible. 

(f)    Entire Agreement. This Agreement, the Stockholders Agreement and the side letter entered into concurrently
with this Agreement by and between the parties hereto constitute the entire agreement of the parties hereto with respect to the subject matter hereof and thereof and supersedes all prior agreements and undertakings, both written and oral, among the
parties hereto with respect to the subject matter hereof and thereof. 
 (g)    Assignment. This Agreement may
not be assigned by operation of law or otherwise without the express written consent of the other parties hereto and any such assignment or attempted assignment without such consent shall be void; provided, however, that the Purchaser
may assign any of its rights and obligations under this Agreement to an Affiliate (which assignment will not release the Purchaser of any of its obligations hereunder). 

(h)    Amendment. This Agreement may not be amended or modified except (i) by an instrument in writing signed by,
or on behalf of, the parties hereto or (ii) by a waiver in accordance with Section 9(i). 

(i)    Waiver. Any party hereto may (i) extend the time for the performance of any of the obligations or other
acts of any other party, (ii) waive any inaccuracies in the representations and warranties of any other party contained herein or in any document delivered by any other party pursuant hereto, or (iii) waive compliance with any of the
agreements of any other party or conditions to such party’s obligations contained herein. Any such extension or waiver shall be valid only if set forth in an instrument in writing signed by the party to be bound thereby. Any waiver of any term
or condition shall not be construed as a waiver of any subsequent breach or a subsequent waiver of the same term or condition, or a waiver of any other term or condition of this Agreement. The failure of any party hereto to assert any of its rights
hereunder shall not constitute a waiver of any of such rights. All rights and remedies existing under this Agreement are cumulative to, and not exclusive of, any rights or remedies otherwise available. 

  
 12 

 (j)    No Third Party Beneficiaries. This Agreement shall be
binding upon and inure solely to the benefit of the parties hereto and their respective successors and permitted assigns and nothing herein, express or implied, is intended to or shall confer upon any other Person, including any union or any
employee or former employee of the Company, any legal or equitable right, benefit or remedy of any nature whatsoever, including any rights of employment for any specified period, under or by reason of this Agreement; except that (i) each
party to the Stockholders Agreement shall be a third party beneficiary to Section 5, (ii) each Purchaser Indemnified Party shall be a third party beneficiary to Section 7(b), and (iii) each
Other Indemnified Party shall be a third party beneficiary to Section 7(c), in each case, with the right to enforce such provision. 

(k)    Law Governing. This Agreement shall be governed by and construed in accordance with the domestic laws of the
State of Delaware without giving effect to any choice or conflict of law provision or rule (whether of the State of Delaware or any other jurisdiction) that would cause the application of the laws of any jurisdiction other than the State of
Delaware. 
 (l)    Remedies. It is specifically understood and agreed that any breach of the provisions of this
Agreement by any party hereto will result in irreparable injury to the other party or third party beneficiaries hereto, that the remedy at law alone will be an inadequate remedy for such breach, and that, in addition to any other legal or equitable
remedies which they may have, such other party or third party beneficiaries may enforce their respective rights by actions for specific performance (to the extent permitted by law) and the Company may refuse to recognize any unauthorized transferee
as one of its stockholders for any purpose, including, without limitation, for purposes of dividend and voting rights, until the relevant party or parties have complied with all applicable provisions of this Agreement and the Stockholders Agreement.

 (m)    Dispute Resolution. The parties hereto shall cooperate in good faith to resolve any dispute that may
arise under or with respect to this Agreement (each, a “Dispute”); provided, however, the parties shall work in good faith to resolve any such Dispute for a reasonable period of time (not to exceed fifteen
(15) business days, unless otherwise agreed by the parties). Any Dispute that cannot be resolved by mutual agreement shall be resolved by arbitration in accordance with the rules of the American Arbitration Association in accordance with its
International Arbitration Rules. Any such arbitration shall be conducted in English in the State of Delaware by a panel of three arbitrators. The parties agree that the existence, conduct and content of any arbitration pursuant to this
Section 9(m) shall be kept confidential and no party shall disclose to any Person any information about such arbitration, except in connection with such arbitration or as may be required by Law. The decision and award of
any such arbitrator shall be final, non-appealable and binding upon the parties involved in such Dispute, and shall be enforceable by any such party in any court of competent jurisdiction. Notwithstanding the
foregoing, (i) any party hereto may elect to seek injunctive relief and other equitable relief from a court of competent jurisdiction with respect a Dispute, and (ii) if a party hereto is seeking an injunction or other equitable relief in
connection with any Dispute, such party may elect to seek such remedy from a court of competent jurisdiction pursuant to Section 9(n) of this Agreement without submitting such Dispute to arbitration pursuant to this
Section 9(m). 

  
 13 

 (n)    Consent to Jurisdiction. SUBJECT TO SECTION 9(M)
ABOVE, EACH OF THE PARTIES HERETO AGREES TO THE EXCLUSIVE JURISDICTION OF ANY COURT WITHIN THE STATE OF DELAWARE, WITH RESPECT TO ANY CLAIM OR CAUSE OF ACTION ARISING UNDER OR RELATING TO THIS AGREEMENT, AND WAIVES PERSONAL SERVICE OF ANY AND ALL
PROCESS UPON IT, AND CONSENTS THAT ALL SERVICES OF PROCESS BE MADE BY REGISTERED OR CERTIFIED MAIL, RETURN RECEIPT REQUESTED, DIRECTED TO IT AT ITS ADDRESS AS SET FORTH IN SECTION 9(d), AND SERVICE SO MADE SHALL BE DEEMED TO BE COMPLETED
WHEN RECEIVED. EACH OF THE PARTIES HERETO WAIVES ANY OBJECTION BASED ON FORUM NON CONVENIENS AND WAIVES ANY OBJECTION TO VENUE OF ANY ACTION INSTITUTED HEREUNDER. NOTHING IN THIS SECTION 9(n) SHALL AFFECT THE RIGHTS OF THE PARTIES
HERETO TO SERVE LEGAL PROCESS IN ANY OTHER MANNER PERMITTED BY LAW. 
 (o)    Counterparts. This Agreement may be
executed and delivered (including by facsimile transmission or portable document format (“.pdf”)) in one or more counterparts, and by the different parties hereto in separate counterparts, each of which when executed shall be deemed to be
an original, but all of which taken together shall constitute one and the same agreement. 
 [SIGNATURE PAGE FOLLOWS] 

  
 14 

 IN WITNESS WHEREOF, the parties hereto have caused this Subscription and Purchase Agreement
to be executed and delivered as of the date and year first written above. 
  

			
	LEGALAPP HOLDINGS, INC.
		
	By:	 	 /s/  Stephen Robertson

		 	Name: Stephen Robertson
		 	Title: CFO
	
	HLUS HOLDINGS LLC
		
	By:	 	  

		 	Name:
		 	Title:

 [Signature Page to the Subscription and Purchase Agreement] 

 IN WITNESS WHEREOF, the parties hereto have caused this Subscription and Purchase Agreement
to be executed and delivered as of the date and year first written above. 
  

			
	LEGALAPP HOLDINGS, INC.
		
	By:	 	  

		 	Name:
		 	Title:
	
	 HLUS HOLDINGS LLC
  

	By:	 	Hamilton Lane Advisors, L.L.C., its manager
		
	By:	 	 /s/  Randy Stilman

		 	Name: Randy Stilman
		 	Title:   CFO

 [Signature Page to the Subscription and Purchase Agreement]EX-10.3

 Exhibit 10.3 

INTAPP, INC. 
 Amended
and Restated 2012 Stock Option and Grant Plan 
  

	SECTION 1.	 GENERAL PURPOSE OF THE PLAN; DEFINITIONS 

Intapp, Inc. (f/k/a LegalApp Holdings, Inc.), a Delaware corporation (the “Company”) established the 2012 Stock Option and Grant Plan
effective as of December 21, 2012 (the “Establishment Date”) and amended and restated it as of May 27, 2021, such amendment effective as of the effective date of the Company’s initial public offering (such amendment
effective date, the “Amendment Date”, and the 2012 Stock Option and Grant Plan, as amended, the “Plan”). The purpose of the Plan is to encourage and enable certain officers, employees, directors, consultants and other key persons
of the Company and its Subsidiaries, upon whose judgment, initiative and efforts the Company largely depends for the successful conduct of its business to acquire a proprietary interest in the Company. It is anticipated that providing such persons
with a direct stake in the Company’s welfare will assure a closer identification of their interests with those of the Company, thereby stimulating their efforts on the Company’s behalf and strengthening their desire to remain with the
Company. 
 The following terms shall be defined as set forth below: 

“Act” means the Securities Act of 1933, as amended, and the rules and regulations thereunder. 

“Award” or “Awards,” except where referring to a particular category of grant under the Plan, shall include
Incentive Stock Options, Non-Qualified Stock Options, Restricted Stock Awards, Unrestricted Stock Awards, or any combination of the foregoing. 

“Board” means the Board of Directors of the Company or its successor entity. 

“Code” means the Internal Revenue Code of 1986, as amended, and any successor Code, and related rules, regulations and
interpretations. 
 “Committee” has the meaning specified in Section 2(a). 

“Exchange Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations thereunder. 

“Fair Market Value” of the Stock on any given date means the fair market value of the Stock determined in good faith by the
Committee; provided, however, that if the Stock trades on a national securities exchange, the Fair Market Value on any given date is the closing sale price on such date. For any date that is not a trading day, the Fair Market Value of
the Stock for such date will be determined by using the closing sale price or the average of the highest bid and lowest asked prices, as appropriate, for the immediately preceding trading day. The Committee can substitute a particular time of day or
other measure of closing sale price if appropriate because of changes in exchange or market procedures. 

  
 1 

 “Incentive Stock Option” means any Stock Option designated and qualified as
an “incentive stock option” as defined in Section 422 of the Code. 

“Non-Qualified Stock Option” means any Stock Option that is not an Incentive Stock
Option. 
 “Option” or “Stock Option” means any option to purchase shares of Stock granted pursuant to
Section 5. 
 “Restricted Stock Award” means Awards granted pursuant to
Section 6. 
 “Stock” means the Common Stock, par value $0.001 per share, of the Company, subject
to adjustments pursuant to Section 3. 
 “Subsidiary” means any corporation or other entity
(other than the Company) in any unbroken chain of corporations or other entities beginning with the Company if each of the corporations or entities (other than the last corporation or entity in the unbroken chain) owns stock or other interests
possessing 50 percent or more of the economic interest or 50 percent or more of the total combined voting power of all classes of stock or other interests in one of the other corporations or entities in the chain. 

“Unrestricted Stock Award” means any Award granted pursuant to Section 7. 

 

	SECTION 2.	 ADMINISTRATION OF PLAN; COMMITTEE AUTHORITY TO SELECT GRANTEES AND DETERMINE AWARDS

 (a) Administration of Plan. The Plan shall be administered by the Board, or at the discretion of the Board,
by a committee of the Board, comprised, except as contemplated by Section 2(c), of not less than two Directors. All references herein to the Committee shall be deemed to refer to the group then responsible for
administration of the Plan at the relevant time (i.e., either the Board of Directors or a committee or committees of the Board, as applicable). 

(b) Powers of Committee. The Committee shall have the power and authority to grant Awards consistent with the terms of the Plan,
including the power and authority: 
 (i) to select the individuals to whom Awards may from time to time be granted; 

(ii) to determine the time or times of grant, and the extent, if any, of Incentive Stock Options,
Non-Qualified Stock Options, Restricted Stock Awards, Unrestricted Stock Awards, or any combination of the foregoing, granted to any one or more grantees; 

(iii) to determine the number of shares of Stock to be covered by any Award; 

(iv) to determine and modify from time to time the terms and conditions, including restrictions, not inconsistent with the terms of the Plan,
of any Award, which terms and conditions may differ among individual Awards and grantees, and to approve the form of written instruments evidencing the Awards; 

  
 2 

 (v) to accelerate at any time the exercisability or vesting of all or any portion of any
Award; 
 (vi) to impose any limitations on Awards granted under the Plan, including limitations on transfers and the like; 

(vii) subject to the provisions of Section 5(a)(ii), to extend at any time the period in which Stock Options may be
exercised, including the extension of any post-termination exercise period of an outstanding Stock Option; 
 (viii) to determine at any time
whether, to what extent, and under what circumstances distribution or the receipt of Stock and other amounts payable with respect to an Award shall be deferred either automatically or at the election of the grantee and whether and to what extent the
Company shall pay or credit amounts constituting interest (at rates determined by the Committee) or dividends or deemed dividends on such deferrals; and 

(ix) at any time to adopt, alter and repeal such rules, guidelines and practices for administration of the Plan and for its own acts and
proceedings as it shall deem advisable; to interpret the terms and provisions of the Plan and any Award (including related written instruments); to make all determinations it deems advisable for the administration of the Plan; to decide all disputes
arising in connection with the Plan; and to otherwise supervise the administration of the Plan. 
 All decisions and interpretations of the
Committee shall be final, conclusive and binding on all persons, including the Company and Plan grantees. 
 (c) Delegation of Authority
to Grant Awards. The Committee, in its discretion, may delegate in writing to the Chief Executive Officer of the Company all or part of the Committee’s authority and duties with respect to the granting of Awards at Fair Market Value, and in
the event of such delegation, such Chief Executive Officer shall be deemed a one-person Committee of the Board. Any such delegation by the Committee shall include a limitation as to the amount of Awards that
may be granted during the period of the delegation and shall contain guidelines as to the determination of the exercise price of any Option, the conversion ratio or price of other Awards and the vesting criteria. The Committee may revoke or amend
the terms of a delegation at any time but such action shall not invalidate any prior actions of the Committee’s delegate or delegates that were consistent with the terms of the Plan. 

(d) Indemnification. Neither the Board nor the Committee, nor any member of either or any delegatee thereof, shall be liable for any
act, omission, interpretation, construction or determination made in good faith in connection with the Plan, and the members of the Board and the Committee (and any delegatee thereof) shall be entitled in all cases to indemnification and
reimbursement by the Company in respect of any claim, loss, damage or expense (including, without limitation, reasonable attorneys’ fees) arising or resulting therefrom to the fullest extent permitted by law and/or under any directors’ and
officers’ liability insurance coverage which may be in effect from time to time. 

  
 3 

	SECTION 3.	 STOCK ISSUABLE UNDER THE PLAN; MERGERS; SUBSTITUTION 

(a) Stock Issuable. The maximum number of shares of Stock reserved and available for issuance under the Plan shall be 22,462,258 shares
of Stock, subject to adjustment as provided in Section 3(b). For purposes of this limitation, the shares of Stock underlying any Awards which are forfeited, canceled, reacquired by the Company, satisfied without the
issuance of Stock or otherwise terminated (other than by exercise) shall be added back to the shares of Stock available for issuance under the Plan. Subject to such overall limitation, shares of Stock may be issued up to such maximum number pursuant
to any type or types of Award. The shares available for issuance under the Plan may be authorized but unissued shares of Stock or shares of Stock reacquired by the Company and held in its treasury. 

(b) Changes in Stock. Subject to Section 3(c) hereof, if, as a result of any reorganization, recapitalization,
reclassification, stock dividend, stock split, reverse stock split or other similar change in the Company’s capital stock, the outstanding shares of Stock are increased or decreased or are exchanged for a different number or kind of shares or
other securities of the Company, or additional shares or new or different shares or other securities of the Company or other non-cash assets are distributed with respect to such shares of Stock or other
securities, or, if, as a result of any merger, consolidation or sale of all or substantially all of the assets of the Company, the outstanding shares of Stock are converted into or exchanged for a different number or kind of securities of the
Company or any successor entity (or a parent or subsidiary thereof), the Committee shall make an equitable or proportionate adjustment in (i) the maximum number of shares reserved for issuance under the Plan, (ii) the number of Stock
Options that can be granted to any one individual grantee, (iii) the number and kind of shares or other securities subject to any then outstanding Awards under the Plan, and (iv) the exercise price and/or exchange price for each share
subject to any then outstanding Stock Options under the Plan, without changing the aggregate exercise price (i.e., the exercise price multiplied by the number of Stock Options ) as to which such Stock Options remain exercisable. The adjustment by
the Committee shall be final, binding and conclusive. No fractional shares of Stock shall be issued under the Plan resulting from any such adjustment, but the Committee in its discretion may make a cash payment in lieu of fractional shares. 

The Committee may also adjust the number of shares subject to outstanding Awards and the exercise price and the terms of outstanding Awards to
take into consideration material changes in accounting practices or principles, extraordinary dividends, acquisitions or dispositions of stock or property or any other event if it is determined by the Committee that such adjustment is appropriate to
avoid distortion in the operation of the Plan, provided that no such adjustment shall be made in the case of an Incentive Stock Option, without the consent of the grantee, if it would constitute a modification, extension or renewal of the
Option within the meaning of Section 424(h) of the Code. 
 (c) Mergers and Other Sale Events. In the case of and subject to the
consummation of (i) the dissolution or liquidation of the Company, (ii) the sale of all or substantially all of the assets of the Company on a consolidated basis to an unrelated person or entity, (iii) a merger, reorganization or
consolidation in which the outstanding shares of Stock are converted into or exchanged for securities of the successor entity and the holders of the Company’s outstanding 

  
 4 

 
voting power immediately prior to such transaction do not own a majority of the outstanding voting power of the successor entity immediately upon completion of such transaction, (iv) the
sale of all or a majority of the outstanding capital stock of the Company to an unrelated person or entity or (v) any other transaction in which, the owners of the Company’s outstanding voting power prior to such transaction do not own at
least a majority of the outstanding voting power of the successor entity immediately upon completion of the transaction (in each case, regardless of the form thereof, a “Sale Event”), unless otherwise provided in the Award agreement or any
other agreement (including employment, retention, change in control, severance or similar agreement with the Company), all outstanding Options issued hereunder shall be assumed or replaced with the same type of award with similar terms and
conditions by the successor entity if the successor entity agrees, as appropriately adjusted, as applicable. Upon the termination of a grantee’s employment by the successor’s entity in connection with or within twelve (12) months
following a Sale Event for any reason other than an involuntary termination by the successor entity for cause, all outstanding Options granted prior to the date of the Sale Event that are in effect as of the date of such termination shall be vested
in full, effective on the date of such termination. In the event that the successor entity following a Sale Event does not assume the Options or issue replacement awards as provided in this Section 3(c), then, unless provided otherwise in an
Award agreement or any other agreement (including employment, retention, change in control, severance or similar agreement with the Company) or determined by the Committee, immediately prior to the date of the Sale Event, the Committee may provide
for any one or more of the following: (A) take such actions as it deems appropriate to provide for the acceleration of the exercisability and/or vesting of some or all outstanding Options in connection with the Sale Event; (B) cancel some
or all outstanding Options in exchange for the right to receive a payment equal to the excess of the Sale Event price of the shares covered by the Options that are cancelled over the grant price of such shares under the Options (in cash, stock,
other property or a combination thereof), or for no consideration in the event that the grant price of such shares under the Options exceeds the Sale Event price of the shares covered by the Options that are cancelled; (C) terminate some or all
outstanding Options upon the effective time of any such Sale Event; or (D) any other treatment as may be determined by the Committee in its sole discretion. In the event of a termination of Options as provided in (C), each grantee shall be
permitted, within a specified period of time prior to the consummation of the Sale Event as determined by the Committee, to exercise the outstanding Options held by such grantee which are then exercisable or will become exercisable as of the
effective time of the Sale Event; provided, however, that the exercise of Options not exercisable prior to the Sale Event shall be subject to the consummation of the Sale Event. The treatment of Restricted Stock Awards in connection with any such
transaction shall be as specified in the relevant Award agreement. 
 (d) Substitute Awards. The Committee may grant Awards under the
Plan in substitution for stock and stock based awards held by employees, directors or other key persons of another corporation in connection with a merger or consolidation of the employing corporation with the Company or a Subsidiary or the
acquisition by the Company or a Subsidiary of property or stock of the employing corporation. The Committee may direct that the substitute awards be granted on such terms and conditions as the Committee considers appropriate in the circumstances.
Any substitute Awards granted under the Plan shall not count against the share limitation set forth in Section 3(a). 

  
 5 

	SECTION 4.	 ELIGIBILITY 

Grantees under the Plan will be such full or part-time officers, employees, directors, consultants and other key persons (including prospective
employees) of the Company and its Subsidiaries who are responsible for, or contribute to, the management, growth or profitability of the Company and its Subsidiaries as are selected from time to time by the Committee in its sole discretion.
Notwithstanding the foregoing, as of the Amendment Date, no Awards shall be granted under the Plan to any person eligible for Awards. 
  

	SECTION 5.	 STOCK OPTIONS 

Any Stock Option granted under the Plan shall be pursuant to a Stock Option Agreement which shall be in such form as the Committee may from
time to time approve. Option agreements need not be identical. 
 Stock Options granted under the Plan may be either Incentive Stock Options
or Non-Qualified Stock Options. Incentive Stock Options may be granted only to employees of the Company or any Subsidiary that is a “subsidiary corporation” within the meaning of Section 424(f)
of the Code. To the extent that any Option does not qualify as an Incentive Stock Option, it shall be deemed a Non-Qualified Stock Option. 

No Incentive Stock Option shall be granted under the Plan after the date which is ten years from the Establishment Date. 

(a) Terms of Stock Options. Stock Options granted under the Plan shall be subject to the following terms and conditions and shall
contain such additional terms and conditions, not inconsistent with the terms of the Plan, as the Committee shall deem desirable. If the Committee so determines, Stock Options may be granted in lieu of cash compensation at the grantee’s
election, subject to such terms and conditions as the Committee may establish, as well as in addition to other compensation. 
 (i)
Exercise Price. The exercise price per share for the Stock covered by a Stock Option shall be determined by the Committee at the time of grant but shall not be less than 100 percent of the Fair Market Value on the date of grant in the
case of Incentive Stock Options. If an employee owns or is deemed to own (by reason of the attribution rules of Section 424(d) of the Code) more than 10 percent of the combined voting power of all classes of stock of the Company or any
parent or subsidiary corporation and an Incentive Stock Option is granted to such employee, the option price of such Incentive Stock Option shall be not less than 110 percent of the Fair Market Value on the grant date. 

(ii) Option Term. The term of each Stock Option shall be fixed by the Committee, but no Stock Option shall be exercisable more than ten
years after the date the Stock Option is granted. If an employee owns or is deemed to own (by reason of the attribution rules of Section 424(d) of the Code) more than 10 percent of the combined voting power of all classes of stock of the
Company or any parent or subsidiary corporation and an Incentive Stock Option is granted to such employee, the term of such Stock Option shall be no more than five years from the date of grant. 

  
 6 

 (iii) Exercisability; Rights of a Stockholder. Stock Options shall become exercisable
at such time or times, whether or not in installments, as shall be determined by the Committee at or after the grant date. The Committee may at any time accelerate the exercisability of all or any portion of any Stock Option. An optionee shall have
the rights of a stockholder only as to shares acquired upon the exercise of a Stock Option and not as to unexercised Stock Options. 
 (iv)
Method of Exercise. Stock Options may be exercised in whole or in part, by giving written notice of exercise to the Company, specifying the number of shares to be purchased. Payment of the purchase price may be made by one or more of the
following methods to the extent provided in the Award agreement or as otherwise provided by the Committee: 
 (A) In cash, by
certified or bank check, or other instrument acceptable to the Committee in U.S. funds payable to the order of the Company in an amount equal to the purchase price of such Option Shares; 

(B) If permitted by the Committee, through the delivery (or attestation to the ownership) of shares of Stock that have been
purchased by the optionee on the open market or have been beneficially owned by the optionee for at least six months and are not then subject to restrictions under any Company plan. Such surrendered shares shall be valued at Fair Market Value on the
exercise date; 
 (C) If permitted by the Committee, by the optionee delivering to the Company a properly executed exercise
notice together with irrevocable instructions to a broker to promptly deliver to the Company cash or a check payable and acceptable to the Company to pay the purchase price; provided that in the event the optionee chooses to pay the purchase
price as so provided, the optionee and the broker shall comply with such procedures and enter into such agreements of indemnity and other agreements as the Committee shall prescribe as a condition of such payment procedure; 

(D) Through net share settlement or a similar procedure involving the withholding of shares of Stock subject to the Option with
a value equal to the purchase price of such Option Shares; or 
 (E) Any other method approved or accepted by the Committee
in its sole discretion. 
 Payment instruments will be received subject to collection. No certificates for shares of Stock so purchased will
be issued to optionee until the Company has completed all steps required by law to be taken in connection with the issuance and sale of the shares, including without limitation (i) the legending of any certificate representing the shares to
evidence the foregoing representations and restrictions, and (ii) obtaining from optionee payment or provision for all withholding taxes due as a result of the exercise of the Option. The delivery of certificates representing the shares of
Stock to be purchased pursuant to the exercise of a Stock Option will be contingent upon receipt from the optionee (or a purchaser acting in his or her stead in accordance with the provisions of the Stock Option) by the Company of the full purchase
price for such shares and the fulfillment of any other requirements contained in the Option Award agreement or applicable provisions of laws. In the event an optionee chooses to pay the purchase price by previously-owned shares of Stock through the
attestation method, the shares of Stock transferred to the optionee upon the exercise of the Stock Option shall be net of the number of shares attested to. 

  
 7 

 (b) Annual Limit on Incentive Stock Options. To the extent required for
“incentive stock option” treatment under Section 422 of the Code, the aggregate Fair Market Value (determined as of the time of grant) of the shares of Stock with respect to which Incentive Stock Options granted under this Plan and
any other plan of the Company or its parent and subsidiary corporations become exercisable for the first time by an optionee during any calendar year shall not exceed $100,000. To the extent that any Stock Option exceeds this limit, it shall
constitute a Non-Qualified Stock Option. 
 (c)
Non-transferability of Options. No Stock Option shall be transferable by the optionee otherwise than by will or by the laws of descent and distribution and all Stock Options shall be exercisable, during
the optionee’s lifetime, only by the optionee, or by the optionee’s legal representative or guardian in the event of the optionee’s incapacity. Notwithstanding the foregoing, the Committee, in its sole discretion, may provide in the
Award agreement regarding a given Option that the optionee may transfer, without consideration for the transfer, his or her Non-Qualified Stock Options to members of his or her immediate family, to trusts for
the benefit of such family members, or to partnerships or other entities in which such family members or trusts are the only owners, provided that the transferee agrees in writing with the Company to be bound by all of the terms and conditions of
this Plan and the applicable Option. 
  

	SECTION 6.	 RESTRICTED STOCK AWARDS 

(a) Nature of Restricted Stock Awards. A Restricted Stock Award is an Award pursuant to which the Company may, in its sole discretion,
grant or sell, at such purchase price as determined by the Committee, in its sole discretion, shares of Stock subject to such restrictions and conditions as the Committee may determine at the time of grant (“Restricted Stock”), which
purchase price shall be payable in cash or other form of consideration acceptable to the Committee. Conditions may be based on continuing employment (or other service relationship) and/or achievement of
pre-established performance goals and objectives. The terms and conditions of each such agreement shall be determined by the Committee, and such terms and conditions may differ among individual Awards and
grantees. 
 (b) Rights as a Stockholder. Upon execution of a written instrument setting forth the Restricted Stock Award and payment
of any applicable purchase price, a grantee shall have the rights of a stockholder with respect to the voting of the Restricted Stock, subject to such conditions contained in the written instrument evidencing the Restricted Stock Award. Unless the
Committee shall otherwise determine, certificates evidencing the Restricted Stock shall remain in the possession of the Company until such Restricted Stock is vested as provided in subsection (d) below of this Section, and the grantee
shall be required, as a condition of the grant, to deliver to the Company a stock power endorsed in blank. 

  
 8 

 (c) Restrictions. Restricted Stock may not be sold, assigned, transferred, pledged or
otherwise encumbered or disposed of except as specifically provided herein or in the Restricted Stock Award agreement. If a grantee’s employment (or other service relationship) with the Company and its Subsidiaries terminates under the
conditions specified in the relevant instrument relating to the Award, or upon such other event or events as may be stated in the instrument evidencing the Award, any unvested portion of the Restricted Stock Award shall be automatically forfeited
upon such termination of employment (or other service relationship) and neither the Company nor its Subsidiaries shall have any further obligations to the grantee. 

(d) Vesting of Restricted Stock. The Committee at the time of grant shall specify the date or dates and/or the attainment of pre-established performance goals, objectives and other conditions on which Restricted Stock shall become vested, subject to such further rights of the Company or its assigns as may be specified in the instrument
evidencing the Restricted Stock Award. 
 (e) Waiver, Deferral and Reinvestment of Dividends. The Restricted Stock Award agreement may
require or permit the immediate payment, waiver, deferral or investment of dividends paid on the Restricted Stock. 
  

	SECTION 7.	 UNRESTRICTED STOCK AWARDS 

(a) Grant or Sale of Unrestricted Stock. The Committee may, in its sole discretion, grant (or sell at par value or such higher purchase
price determined by the Committee) an Unrestricted Stock Award to any grantee, pursuant to which such grantee may receive shares of Stock free of any vesting restrictions (“Unrestricted Stock”) under the Plan. Unrestricted Stock Awards may
be granted or sold as described in the preceding sentence in respect of past services or other valid consideration, or in lieu of any cash compensation due to such individual. 

(b) Elections to Receive Unrestricted Stock In Lieu of Compensation. Upon the request of a grantee and with the consent of the
Committee, each such grantee may, pursuant to an advance written election delivered to the Company no later than the date specified by the Committee, receive a portion of the cash compensation otherwise due to such grantee in the form of shares of
Unrestricted Stock either currently or on a deferred basis. 
 (c) Restrictions on Transfers. The right to receive shares of
Unrestricted Stock on a deferred basis may not be sold, assigned, transferred, pledged or otherwise encumbered, other than by will or the laws of descent and distribution. 
  

	SECTION 8.	 TAX WITHHOLDING 

(a) Payment by Grantee. Each grantee shall, no later than the date as of which the value of an Award or of any Stock or other amounts
received thereunder first becomes includable in the gross income of the grantee for Federal income tax purposes, pay to the Company, or make arrangements satisfactory to the Committee regarding payment of, any federal, state, or local taxes of any
kind required by law to be withheld with respect to such income. The Company and its Subsidiaries shall, to the extent permitted by law, have the right to deduct any such taxes from any payment of any kind otherwise due to the grantee. The
Company’s obligation to deliver stock certificates to any grantee is subject to and conditioned on tax obligations being satisfied by the grantee. 

  
 9 

 (b) Payment in Stock. Subject to approval by the Committee, a grantee may elect to
have the minimum required tax withholding obligation satisfied, in whole or in part, by (i) authorizing the Company to withhold from shares of Stock to be issued pursuant to any Award a number of shares with an aggregate Fair Market Value (as
of the date the withholding is effected) that would satisfy the withholding amount due, or (ii) transferring to the Company shares of Stock owned by the grantee with an aggregate Fair Market Value (as of the date the withholding is effected)
that would satisfy the minimum withholding amount due. 
  

	SECTION 9.	 TRANSFER, LEAVE OF ABSENCE, ETC. 

For purposes of the Plan, the following events shall not be deemed a termination of employment: 

(a) a transfer to the employment of the Company from a Subsidiary or from the Company to a Subsidiary, or from one Subsidiary to another; or

 (b) an approved leave of absence for military service or sickness, family leave, parental leave, or for any other purpose approved by the
Company, if the employee’s right to re-employment is guaranteed either by a statute or by contract or under the policy pursuant to which the leave of absence was granted or if the Committee otherwise so
provides in writing. 
  

	SECTION 10.	 AMENDMENTS AND TERMINATION 

The Board may, at any time, amend or discontinue the Plan and the Committee may, at any time, amend or cancel any outstanding Award (or provide
substitute Awards at the same or reduced exercise or purchase price or with no exercise or purchase price in a manner not inconsistent with the terms of the Plan), but such price, if any, must satisfy the requirements which would apply to the
substitute or amended Award if it were then initially granted under this Plan for the purpose of satisfying changes in law or for any other lawful purpose, but no such action shall adversely affect rights under any outstanding Award without the
holder’s consent. If and to the extent determined by the Committee to be required by the Code to ensure that Incentive Stock Options granted under the Plan are qualified under Section 422 of the Code, Plan amendments shall be subject to
approval by the Company’s stockholders who are eligible to vote at a meeting of stockholders. Nothing in this Section 10 shall limit the Board’s or Committee’s authority to take any action permitted pursuant
to Section 3(c). 
  

	SECTION 11.	 STATUS OF PLAN 

With respect to the portion of any Award that has not been exercised and any payments in cash, Stock or other consideration not received by a
grantee, a grantee shall have no rights greater than those of a general creditor of the Company unless the Committee shall otherwise expressly determine in connection with any Award or Awards. In its sole discretion, the Committee may authorize the
creation of trusts or other arrangements to meet the Company’s obligations to deliver Stock or make payments with respect to Awards hereunder, provided that the existence of such trusts or other arrangements is consistent with the
foregoing sentence. 

  
 10 

	SECTION 12.	 GENERAL PROVISIONS 

(a) No Distribution; Compliance with Legal Requirements. The Committee may require each person acquiring Stock pursuant to an Award to
represent to and agree with the Company in writing that such person is acquiring the shares without a view to distribution thereof. No shares of Stock shall be issued pursuant to an Award until all applicable securities law and other legal and stock
exchange or similar requirements have been satisfied. The Committee may require the placing of such stop-orders and restrictive legends on certificates for Stock and Awards as it deems appropriate. 

(b) Delivery of Stock Certificates. Stock certificates to grantees under this Plan shall be deemed delivered for all purposes when the
Company or a stock transfer agent of the Company shall have mailed such certificates in the United States mail, addressed to the grantee, at the grantee’s last known address on file with the Company. 

(c) Other Compensation Arrangements; No Employment Rights. Nothing contained in this Plan shall prevent the Board from adopting other or
additional compensation arrangements, including trusts, and such arrangements may be either generally applicable or applicable only in specific cases. The adoption of this Plan and the grant of Awards do not confer upon any employee any right to
continued employment with the Company or any Subsidiary. 
 (d) Trading Policy Restrictions. Option exercises and other Awards under
the Plan shall be subject to such Company’s insider-trading-policy-related restrictions, terms and conditions as may be established by the Committee, or in accordance with policies set by the Committee, from time to time. 

(e) Designation of Beneficiary. Each grantee to whom an Award has been made under the Plan may designate a beneficiary or beneficiaries
to exercise any Award or receive any payment under any Award payable on or after the grantee’s death. Any such designation shall be on a form provided for that purpose by the Committee and shall not be effective until received by the Company.
If no beneficiary has been designated by a deceased grantee, or if the designated beneficiaries have predeceased the grantee, the beneficiary shall be the grantee’s estate. 

 

	SECTION 13.	 GOVERNING LAW 

This Plan and all Awards and actions taken thereunder shall be governed by Delaware law, applied without regard to conflict of law principles.

  
 11

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00329-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00329-of-00352.parquet"}]]